5,11,17,23,29-penta-tert-butylhexacyclo[25.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹.1²¹,²⁵]pentatriaconta-1(31),3,5,7(35),9,11,13(34),15,17,19(33),21,23,25(32),27,29-pentadecaene-31,32,33,34,35-pentol
Structure Info
- Chemspace ID
- CSSB02125551515 (In-Stock Building Blocks)
- MFCD
- MFCD00210028
- IUPAC Name
- 5,11,17,23,29-penta-tert-butylhexacyclo[25.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹.1²¹,²⁵]pentatriaconta-1(31),3,5,7(35),9,11,13(34),15,17,19(33),21,23,25(32),27,29-pentadecaene-31,32,33,34,35-pentol
- Mol formula
- C55H70O5
- Mol weight
- 811 Da
- Catalog Number(s)
- 135929, 208882, 6695AL, 81475-22-1, A603914, AA003LZ3, AB68347, ACM81475221, ACM81475221-1, ACM814752211, ACMPYX427, AG003M1V, AR003MQV, B2221, B750288, BD100352, CS-0366751, D88908, D88908-0.1G, EC003O7N, FT59574, HY-W326297, LN01740690, OR1023355, ST003NIN, TS-04688, TX003N7J, U98645, Y1234939, Y4246919, ZXC172272
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 16.67
- Heavy atoms count
- 60
- Rotatable bond count
- 5
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.454
- Polar surface area (Å)
- 101
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 5
- Zoom the structure
- CSSB02125551515
Items Overall 41 items from 15 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 95 | 100 mg | 144.00 | |
Description: Name:4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 100 mg | 144.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 250 mg | 291.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 1 g | 732.00 | |
Description: Name:4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| 1st Scientific CN | 7 days | China To: | 95 | 100 mg | 165.00 | |
| 1st Scientific CN | 7 days | China To: | 95 | 250 mg | 330.00 | |
| 1st Scientific CN | 7 days | China To: | 95 | 1 g | 990.00 | |
Description: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| AiFChem CN | 10 days | China To: | 95 | 100 mg | 134.00 | |
| AiFChem CN | 10 days | China To: | 95 | 250 mg | 270.00 | |
| AiFChem CN | 10 days | China To: | 95 | 1 g | 679.00 | |
Description: 4-tert-Butylcalix[5]arene; Hazard statement: H315, H319; CAS: 81475-22-1 | ||||||
| Astatech CN | 10 days | China To: | 95 | 100 mg | 145.20 | |
Description: 4-TERT-BUTYLCALIX[5]ARENE; CAS: 81475-22-1 | ||||||
| Angene International Limited | 10 days | China To: | 95 | 100 mg | 146.70 | |
| Angene International Limited | 10 days | China To: | 95 | 250 mg | 293.40 | |
| Angene International Limited | 10 days | China To: | 95 | 1 g | 733.50 | |
Description: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 25 mg | 47.15 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 100 mg | 94.30 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 250 mg | 188.60 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 1 g | 564.65 | |
| A2B Chem | 12 days | United States To: | 98 | 25 mg | 51.75 | |
| A2B Chem | 12 days | United States To: | 98 | 100 mg | 100.05 | |
| A2B Chem | 12 days | United States To: | 98 | 250 mg | 197.80 | |
| A2B Chem | 12 days | United States To: | 98 | 1 g | 585.35 | |
Description: 4-Tert-Butylcalix[5]Arene; CAS: 81475-22-1 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 25 mg | 61.60 | |
| AA BLOCKS | 12 days | United States To: | 98 | 100 mg | 82.50 | |
| AA BLOCKS | 12 days | United States To: | 98 | 1 g | 733.70 | |
Description: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| Ambeed CN | 12 days | China To: | 95 | 100 mg | 129.60 | |
| Ambeed CN | 12 days | China To: | 95 | 250 mg | 261.90 | |
| Ambeed CN | 12 days | China To: | 95 | 1 g | 658.80 | |
Description: Name: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 95 | 100 mg | 129.60 | |
Description: Name: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 98 | 25 mg | 67.10 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 100 mg | 130.90 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 250 mg | 257.40 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 1 g | 742.50 | |
Description: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| eNovation CN | 20 days | China To: | 95 | 100 mg | 126.50 | |
| eNovation CN | 20 days | China To: | 95 | 250 mg | 218.50 | |
| eNovation CN | 20 days | China To: | 95 | 1 g | 523.25 | |
Description: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 25 mg | 44.00 | |
| 10X CHEM | TBD | United States To: | 98 | 100 mg | 83.60 | |
| 10X CHEM | TBD | United States To: | 98 | 250 mg | 163.90 | |
| 10X CHEM | TBD | United States To: | 98 | 1 g | 485.10 | |
Description: 4-tert-Butylcalix[5]arene; CAS: 81475-22-1 | ||||||
| TCI America | TBD | United States To: | 98 | 100 mg | 83.16 | |
Description: 4-tert-Butylcalix[5]arene, C55H70O5, CHO, 811.16 g/mol; CAS: 81475-22-1 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 5,11,17,23-tetra-tert-butylpentacyclo[19.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-25,26,27,28-tetrol - CSSB00016993598](/st/structure/200/2afd9ce1faad234e503769526b86304c/CC%2528C%2529%2528C%2529C1%253DCC2%253DC%2528O%2529C%2528CC3%253DC%2528O%2529C%2528CC4%253DC%2528O%2529C%2528CC5%253DC%2528O%2529C%2528C2%2529%253DCC%2528%253DC5%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC4%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC3%2529C%2528C%2529%2528C%2529C%2529%253DC1.png)
![Chemical structure of 5,11,17,23,29,35-hexa-tert-butylheptacyclo[31.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹.1²¹,²⁵.1²⁷,³¹]dotetraconta-1(37),3,5,7(42),9,11,13(41),15,17,19(40),21,23,25(39),27,29,31(38),33,35-octadecaene-37,38,39,40,41,42-hexol - CSSB02125555970](/st/structure/200/7eadb83ac6630fbc32b7084ec23074b9/CC%2528C%2529%2528C%2529C1%253DCC2%253DC%2528O%2529C%2528CC3%253DC%2528O%2529C%2528CC4%253DC%2528O%2529C%2528CC5%253DC%2528O%2529C%2528CC6%253DC%2528O%2529C%2528CC7%253DC%2528O%2529C%2528C2%2529%253DCC%2528%253DC7%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC6%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC5%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC4%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC3%2529C%2528C%2529%2528C%2529C%2529%253DC1.png)
![Chemical structure of 5,11,17,23,29,35,41,47-octa-tert-butylnonacyclo[43.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹.1²¹,²⁵.1²⁷,³¹.1³³,³⁷.1³⁹,⁴³]hexapentaconta-1(49),3,5,7(56),9,11,13(55),15,17,19(54),21,23,25(53),27,29,31(52),33,35,37(51),39,41,43(50),45,47-tetracosaen-49,50,51,52,53,54,55,56-octol - CSSB00028087818](/st/structure/200/4fc827cac3fa13792ca0e280bf321838/CC%2528C%2529%2528C%2529C1%253DCC2%253DC%2528O%2529C%2528CC3%253DC%2528O%2529C%2528CC4%253DC%2528O%2529C%2528CC5%253DC%2528O%2529C%2528CC6%253DC%2528O%2529C%2528CC7%253DC%2528O%2529C%2528CC8%253DC%2528O%2529C%2528CC9%253DC%2528O%2529C%2528C2%2529%253DCC%2528%253DC9%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC8%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC7%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC6%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC5%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC4%2529C%2528C%2529%2528C%2529C%2529%253DCC%2528%253DC3%2529C%2528C%2529%2528C%2529C%2529%253DC1.png)
![Chemical structure of 2,4-di-tert-butyl-6-[(3,5-di-tert-butyl-2-hydroxyphenyl)methyl]phenol - CSSB00020676530](/st/structure/200/65be5b1ab638acf108ba71df24cc86f9/CC%2528C%2529%2528C%2529C1%253DCC%2528CC2%253DCC%2528%253DCC%2528%253DC2O%2529C%2528C%2529%2528C%2529C%2529C%2528C%2529%2528C%2529C%2529%253DC%2528O%2529C%2528%253DC1%2529C%2528C%2529%2528C%2529C.png)
![Chemical structure of 5,11,17,23-tetra-tert-butyl-26,28-dimethoxypentacyclo[19.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-25,27-diol - CSSB00121577619](/st/structure/200/0fb9c7554f00decc7e5ca6b9cb6abccd/COC1%253DC2CC3%253DCC%2528%253DCC%2528CC4%253DCC%2528%253DCC%2528CC5%253DCC%2528%253DCC%2528CC1%253DCC%2528%253DC2%2529C%2528C%2529%2528C%2529C%2529%253DC5O%2529C%2528C%2529%2528C%2529C%2529%253DC4OC%2529C%2528C%2529%2528C%2529C%2529%253DC3O%2529C%2528C%2529%2528C%2529C.png)


